Clinical Trial Update: Artemisinin With Risperidone for First-Episode and Drug-Naive Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating artemisinin in combination with risperidone for first-episode and drug-naive schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Artemisinin (Artemisinin)
• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: Beijing HuiLongGuan Hospital | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED